Sunday 18 October 2026
Export VJET’s income statement to Excel — free account
Flyte Aviation, Inc.
VJET Healthcare Medical Devices
Flyte Aviation, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $819,000.00, up 95.0% from fiscal 2024. In the quarter to June 2026, revenue grew 380.7%, EPS grew 87.3%, free cash flow fell 26.7% and total debt rose 160.0%, each against the same quarter a year earlier. Operating cash flow growth for five consecutive years.
0.84
0.14
−14.29%
Follow VJET
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.25 | 0.00 | 0.00 | 0.00 |
P/S ratio |
45.59 | 24.15 | 19.98 | 12.28 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(15.24) | (13.08) | (7.92) | (8.22) | |
P/B ratio |
5.16 | 2.97 | 2.42 | 1.37 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
44.91 | 28.12 | 22.72 | 13.18 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(3.40) | (2.78) | (2.88) | (2.70) | |
EV/FCF |
(3.39) | (2.77) | (2.87) | (2.69) | |
Quick Ratio |
0.41 | 0.06 | 0.04 | 0.15 | |
Current Ratio |
0.46 | 0.10 | 0.06 | 0.19 | |
Net Debt/EBITDA |
0.30 | (0.32) | (1.53) | (0.44) | |
Debt/Assets |
5.09% | 19.41% | 9.16% | 8.92% | |
Debt/Equity |
0.20 | 0.46 | 0.35 | 0.19 | |
Asset Turnover |
0.03 | 0.04 | 0.04 | 0.06 | |
Operating CF/Net income |
0.97 | 0.26 | 0.92 | 1.12 | |
Capex/Depreciation |
0.00 | 0.00 | (0.01) | (0.02) | |
Interest Coverage |
(36.40) | (120.26) | (19.48) | (19.39) | |
Research and Development Expense of Revenue |
122.12% | 137.82% | 34.49% | 13.94% | |
Selling, General and Administrative Expense of Revenue |
1,306.64% | 1,157.98% | 592.36% | 383.81% | |
Intangible Assets out of Total Assets |
0.89 | 0.96 | 0.91 | 0.86 | |
Share Based Compensation of Revenue |
30.97% | 33.19% | 14.81% | 26.10% | |
Graham Net Nets |
(0.50) | (0.45) | (1.11) | (0.73) | |
Graham Number |
104.77 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
396.41% | (101.90%) | (130.64%) | (81.06%) | |
Free Cash Flow Yield |
(29.04%) | (42.04%) | (39.60%) | (39.85%) | |
Revenue per Share |
0.17 | 0.22 | 0.20 | 0.37 | |
Operating CF per Share |
(1.65) | (1.40) | (1.28) | (1.03) | |
Capex per Share |
0.00 | 0.00 | 0.00 | (0.01) | |
Free Cash Flow per Share |
(1.65) | (1.40) | (1.28) | (1.04) | |
Cash per Share |
1.56 | 0.08 | 0.20 | 0.66 | |
Shareholders Equity per Share |
4.88 | 6.15 | 4.18 | 6.19 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
4.88 | 6.15 | 4.18 | 6.19 | |
Free Cash Flow |
(2.18) | (1.51) | (2.80) | (2.88) | |
Working Capital |
(2.86) | (3.52) | (18.49) | (10.94) | |
Capital Expenditures |
0.00 | 0.00 | (0.01) | (0.01) | |
Net Current Asset Value |
(16.56) | (8.82) | (24.68) | (17.22) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.01 | 0.01 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
0.12 | 0.11 | 0.17 | 0.12 | |
Average Payables |
0.89 | 0.86 | 0.86 | 1.13 | |
Average Inventory |
0.03 | 0.06 | 0.07 | 0.07 | |
Average Assets |
26.11 | 21.82 | 29.94 | 31.22 | |
Average Common Equity |
9.64 | 9.20 | 8.54 | 11.84 |
Columns are period end dates